Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cas9 gets a classmate

Nature Biotechnology volume 33, pages 1240–1241 (2015)Cite this article

Subjects

Cpf1 is one of a growing number of class II CRISPR-Cas effectors that expand both our understanding of bacterial immunity and our genome-editing toolset.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Cas9, Cpf1 and their respective interference mechanisms.

References

  1. Zetsche, B. et al. Cell 163, 759–777 (2015).

    Article  CAS  Google Scholar 

  2. Makarova, K.S. et al. Nat. Rev. Microbiol. 13, 722–736 (2015).

    Article  CAS  Google Scholar 

  3. Sapranauskas, R. et al. Nucleic Acids Res. 39, 9275–9282 (2011).

    Article  CAS  Google Scholar 

  4. Jinek, M. et al. Science 337, 816–821 (2012).

    Article  CAS  Google Scholar 

  5. Gasiunas, G., Barrangou, R., Horvath, P. & Siksnys, V. Proc. Natl. Acad. Sci. USA 109, E2579–E2586 (2012).

    Article  CAS  Google Scholar 

  6. Esvelt, K.M. et al. Nat. Methods 10, 1116–1121 (2013).

    Article  CAS  Google Scholar 

  7. Shmakov, S. et al. Mol. Cell 60, 385–397 (2015).

    Article  CAS  Google Scholar 

  8. Hendel, A. et al. Nat. Biotechnol. 33, 985–989 (2015).

    Article  CAS  Google Scholar 

  9. Maresca, M., Lin, V.G., Guo, N. & Yang, Y. Genome Res. 23, 539–546 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Erik J. Sontheimer is at the RNA Therapeutics Institute, Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.,

    Erik J Sontheimer

  2. Scot A. Wolfe is in the Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.,

    Scot A Wolfe

Authors
  1. Erik J Sontheimer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scot A Wolfe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Erik J Sontheimer or Scot A Wolfe.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sontheimer, E., Wolfe, S. Cas9 gets a classmate. Nat Biotechnol 33, 1240–1241 (2015). https://doi.org/10.1038/nbt.3426

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3426

This article is cited by

Search

Advanced search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology